Investor Relations
Welcome to MedVasc's Investor Relations website!
We appreciate your interest in our company and we are dedicated to providing all our current and future investors with timely and transparent information. If you have any questions, regarding our traction, investment strategy or future opportunities for investment, please feel free to reach out to CEO Cathrin Johansson.
Stay up to date on our performance and future investment opportunities by signing up to our newsletter.
Latest news
MedVasc and Solutio™ Featured in Venous News
June 8, 2026
MedVasc and the Solutio™ catheter system were recently featured in Venous News, highlighting the company’s ongoing development efforts and the clinical need Solutio is…
MedVasc Selected for Innovate Nordics 2026
June 8, 2026
MedVasc has been selected to participate in Innovate Nordics 2026, a prestigious accelerator program hosted by the Swedish-American Chamber of Commerce in New York…
Dr. Michael Åkesson awarded Honorary Membership in the Seldinger Society
June 8, 2026
MedVasc is pleased to announce that the company’s founder and Chief Medical Officer, Dr. Michael Åkesson, has been named this year’s Swedish Honorary Member…
MedVasc and Solutio™ Featured in Venous News
June 8, 2026
MedVasc and the Solutio™ catheter system were recently featured in Venous News, highlighting the company’s ongoing development efforts and the clinical need Solutio is…
MedVasc Selected for Innovate Nordics 2026
June 8, 2026
MedVasc has been selected to participate in Innovate Nordics 2026, a prestigious accelerator program hosted by the Swedish-American Chamber of Commerce in New York…
Dr. Michael Åkesson awarded Honorary Membership in the Seldinger Society
June 8, 2026
MedVasc is pleased to announce that the company’s founder and Chief Medical Officer, Dr. Michael Åkesson, has been named this year’s Swedish Honorary Member…
